IRONWOOD PHARMACEUTICALS INC

By person

33 insiders · 316 transactions

9.8×

Thomas McCourt holds 9.8 times base salary in stock. $8.58M of shares against $867.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas McCourt last reported holding, valued at $4.52, the price Class A Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Currie Mark G

Director

—

$17.72M (20) scheduled

−$17.72M

676,900

$3.06M

+64.9%

MCCOURT Thomas A

Chief Executive Officer

—

$14.80M (50)

−$14.80M

1,898,838

$8.58M

+4,034%

Hecht Peter M

Chief Executive Officer

—

$3.87M (7) scheduled

−$3.87M

2,231,916

$10.09M

−52.4%

Gilbert Halley E

Chief Admin Officer & SVP

—

$3.62M (24) scheduled

−$3.62M

265,991

$1.20M

+279.3%

Rickard Jason

SVP, Chief Operating Officer

—

$2.42M (28)

−$2.42M

376,316

$1.70M

+56.0%

DENNER ALEXANDER J

Director

$22.83M (8)

$20.53M (2)

+$2.30M

25,902,490

$117.08M

−13.5%

Shetzline Michael

SVP, CMO, Head-Res&Drug

—

$1.75M (21)

−$1.75M

1,179,462

$5.33M

+105.6%

John Minardo

Chief Legal Officer

—

$1.32M (11)

−$1.32M

500,498

$2.26M

—

Silver Ronald

PFO & PAO

—

$1.20M (21) scheduled

−$1.20M

755,250

$3.41M

+43.4%

McHugh Julie

Director

—

$827.16K (13)

−$827.16K

389,122

$1.76M

+89.7%

Consylman Gina

SVP, CFO & Treasurer

—

$639.35K (32)

−$639.35K

392,616

$1.77M

+1,759%

Mallon Mark

Chief Executive Officer

—

$612.48K (5)

−$612.48K

470,605

$2.13M

—

OLANOFF LAWRENCE S

Director

—

$519.28K (13)

−$519.28K

91,395

$413.11K

+211.9%

Moukheibir Catherine

Director

—

$517.69K (2)

−$517.69K

181,425

$820.04K

—

Davis Andrew

SVP, Chief Business Officer

—

$493.29K (8)

−$493.29K

284,685

$1.29M

+75.2%

MacDonald Kelly

Chief Accounting Officer

—

$455.97K (17)

−$455.97K

93,041

$420.55K

+27.0%

Emany Sravan Kumar

SVP, COO and CFO

$400.33K (2)

$120.93K (2)

+$279.41K

309,572

$1.40M

—

Kessler Marla L

Director

—

$199.73K (2) scheduled

−$199.73K

229,364

$1.04M

—

Owens Edward P

Director

$137.07K (3)

—

+$137.07K

281,720

$1.27M

+68.0%

Martini Gregory S.

Chief Financial Officer

—

$104.16K (4)

−$104.16K

297,213

$1.34M

+250.7%

Gaskins Tammi L

Chief Commercial Officer

—

$102.89K (5)

−$102.89K

350,350

$1.58M

+42.9%

Kilroy Conor

SVP, GC & Secretary

—

$80.21K (8)

−$80.21K

122,336

$552.96K

+13.2%

Duane Jon R

Director

$60.20K (1)

—

+$60.20K

253,820

$1.15M

—

Graney Thomas

Chief Financial Officer

—

$31.75K (2)

−$31.75K

42,013

$189.90K

+85.6%

WALSH CHRISTOPHER T PHD

Director

—

374,525

$1.69M

+0.1%

Shepard Jay

Director

—

235,036

$1.06M

—

Dreyfus Andrew

Director

—

228,313

$1.03M

—

MCGUIRE TERRANCE

Director

—

145,999

$659.92K

+25.2%

Silber Jeffrey

SVP, CMO, Head-Res&Drug

—

137,036

$619.40K

—

Fanucci Marsha

Director

—

132,663

$599.64K

+26.5%

WILLIAMS DOUGLAS E

Director

—

87,800

$396.86K

+46.3%

SCHULMAN AMY W

Director

—

38,242

$172.85K

—

Huyett William

Chief Operating Officer

—

27,546

$124.51K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Silver Ronald

7 Jul 2026

PFO & PAO

Sold on a plan

127,890

$4.52

$578.06K

McHugh Julie

16 Jun 2026

Director

Sold on a plan

21,571

$3.73

$80.46K

Silver Ronald

5 Jan 2026

Principal Accounting Officer

Sold on a plan

35,416

$4.60

$162.91K

McHugh Julie

10 Jun 2024

Director

Sold on a plan

22,766

$6.29

$143.20K

Kessler Marla L

14 Dec 2023

Director

Sold on a plan

9,926

$11.19

$111.07K

MCCOURT Thomas A

30 May 2023

Chief Executive Officer

Sold on a plan

26,632

$10.70

$284.96K

Showing 250 of 316 transactions. The figures above use every one of them.

IRONWOOD PHARMACEUTICALS INC

By person

Individual transactions

What was left out